Literature DB >> 11122339

Cloning, distribution and functional analysis of the type III sodium channel from human brain.

Y H Chen1, T J Dale, M A Romanos, W R Whitaker, X M Xie, J J Clare.   

Abstract

The type III voltage-gated sodium channel was cloned from human brain. The full-length cDNA has 89% identity with rat type III, and the predicted protein (1951 amino acids) has 55 differences. The expression pattern of human type III mRNA was determined in adult brain tissue and, in contrast to rat, was detected in many regions, including caudate nucleus, cerebellum, hippocampus and frontal lobe. The human type III channel was stably expressed in Chinese hamster ovary (CHO) cells and its biophysical properties compared to the human type II channel using identical conditions. The voltage dependence and kinetics of activation were found to be similar to that of type II. The kinetics of inactivation of the two human subtypes were also similar. However, type III channels inactivated at more hyperpolarized potentials and were slower to recover from inactivation than type II. When expressed in human embryonic kidney (HEK293T) cells, type III channels produced currents with a prominent persistent component, which were similar to those reported for rat type II [Ma et al. (1997) Neuron, 19, 443-452]. However, unlike type II, this was prominent even in the absence of coexpressed G-proteins, suggesting type III may adopt this gating mode more readily. The distinct properties of the channel, together with its wide distribution in adult brain, suggest that in humans, type III may have important physiological roles under normal, and perhaps also pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122339

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  27 in total

Review 1.  Expression and distribution of voltage-gated sodium channels in the cerebellum.

Authors:  Kristin L Schaller; John H Caldwell
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

2.  The sodium channel {beta}3-subunit induces multiphasic gating in NaV1.3 and affects fast inactivation via distinct intracellular regions.

Authors:  Fiona S Cusdin; Daniel Nietlispach; Joseph Maman; Timothy J Dale; Andrew J Powell; Jeffrey J Clare; Antony P Jackson
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

3.  Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation.

Authors:  Brian W Jarecki; Patrick L Sheets; James O Jackson; Theodore R Cummins
Journal:  J Physiol       Date:  2008-07-03       Impact factor: 5.182

Review 4.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

5.  Biophysical characterisation of the persistent sodium current of the Nav1.6 neuronal sodium channel: a single-channel analysis.

Authors:  Aurélien Chatelier; Juan Zhao; Patrick Bois; Mohamed Chahine
Journal:  Pflugers Arch       Date:  2010-03-05       Impact factor: 3.657

6.  Molecular and functional differences in voltage-activated sodium currents between GABA projection neurons and dopamine neurons in the substantia nigra.

Authors:  Shengyuan Ding; Wei Wei; Fu-Ming Zhou
Journal:  J Neurophysiol       Date:  2011-08-31       Impact factor: 2.714

7.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

Review 8.  Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.

Authors:  Jacob M Hull; Lori L Isom
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

9.  Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine.

Authors:  Xin Qiao; Guangchun Sun; Jeffrey J Clare; Taco R Werkman; Wytse J Wadman
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  Modulation of Na(v)1.5 by beta1-- and beta3-subunit co-expression in mammalian cells.

Authors:  Seong-Hoon Ko; Paul W Lenkowski; Hwa C Lee; J Paul Mounsey; Manoj K Patel
Journal:  Pflugers Arch       Date:  2004-09-28       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.